Multiple Choice
What does the provider understand about the issue of "Diabetic Renal Protection" with angiotensin-converting enzyme (ACE) medications? Diabetes mellitus patients:
A) Have a reduced rate of renal progression, but still need to be discontinued when advanced renal issues present
B) Who start these medications never progress to renal nephropathy
C) With early renal dysfunction will see it reverse when on ACE medications
D) Without renal issues are the only ones who benefit from ACE protection
Correct Answer:

Verified
Correct Answer:
Verified
Q17: A potentially life-threatening adverse response to angiotensin-converting
Q18: Larry has heart failure, which is being
Q19: The choice of diuretic to use in
Q20: Direct renin inhibitors have the following properties.
Q21: Niaspan is less likely to cause which
Q23: Rodrigo has been prescribed procainamide after a
Q24: Dulcea has type 2 diabetes and a
Q25: Laboratory monitoring for patients on angiotensin-converting enzyme
Q26: Because of the pattern of cholesterol synthesis,
Q27: Ray has been diagnosed with hypertension and